← Leaderboards
Anne M Murray
Minneapolis Medical Research Fdn, Inc.
$30,908,651
Attributed
$44,721,808
Total exposure
10
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $16.4M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$87,600,000 · 11
By mechanism
U19$55,429,000 · 5
U01$20,656,114 · 1
RF1$7,584,166 · 2
R01$3,181,075 · 2
K23$749,645 · 1
Top collaborators
- John James Mcneil12 shared
- Andrew T Chan10 shared
- Joanne Ryan8 shared
- Michelle M Mielke4 shared
- Danny Liew3 shared
- Rory Wolfe1 shared
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposParticipantDementiaElderlyInsightFollow-UpAgedDisabilityImpaired CognitionAustraliaAgingCohortEventAspirinCognitiveStrokeFundingMinorityDoseLifeLongitudinal StudiesCessation Of LifeAging PopulationCardiovascular Diseases
Grant awards (36)
Sex-specific risk factors and trajectories of blood biomarkers for Alzheimer's disease and related dementias$334,342
R01 · FY2025 · AG · contact PI
Sex-specific risk factors and trajectories of blood biomarkers for Alzheimer's disease and related dementias$169,669
R01 · FY2025 · AG · contact PI
Sex-specific risk factors and trajectories of blood biomarkers for Alzheimer's disease and related dementias$387,497
RF1 · FY2024 · AG · contact PI
ASPirin in Reducing Events in the Elderly - eXTension$8,032,026
U19 · FY2023 · AG · contact PI
Main Administrative Core$2,927,614
U19 · FY2023 · AG · contact PI
ConProject-006$34,776
U19 · FY2023 · AG · contact PI
ConProject-005$19,131
U19 · FY2023 · AG · contact PI
ASPirin in Reducing Events in the Elderly - eXTension$7,969,915
U19 · FY2022 · AG · contact PI
Sex-specific risk factors and trajectories of blood biomarkers for Alzheimer's disease and related dementias$4,159,504
RF1 · FY2022 · AG · contact PI
Main Administrative Core$4,118,443
U19 · FY2022 · AG · contact PI
ConProject-005$103,105
U19 · FY2022 · AG · contact PI
ASPirin in Reducing Events in the Elderly - eXTension$8,509,004
U19 · FY2021 · AG · contact PI
Main Administrative Core$2,008,967
U19 · FY2021 · AG · contact PI
ASPirin in Reducing Events in the Elderly - eXTension$340,492
U19 · FY2021 · AG · contact PI
ASPirin in Reducing Events in the Elderly - eXTension$8,333,959
U19 · FY2020 · AG · contact PI
Main Administrative Core$1,622,133
U19 · FY2020 · AG · contact PI
ASPirin in Reducing Events in the Elderly - eXTension$238,377
U19 · FY2020 · AG · contact PI
Main Administrative Core$61,151
U19 · FY2020 · AG · contact PI
ASPirin in Reducing Events in the Elderly - eXTension$9,454,419
U19 · FY2019 · AG · contact PI
Main Administrative Core$1,655,488
U19 · FY2019 · AG · contact PI
ASPirin in Reducing Events in the Elderly$5,794,244
U01 · FY2018 · AG · contact PI
The Natural History of Cognitive Decline in Chronic Kidney Disease: Renal, Vascular and Alzheimer's Disease Contributions$3,037,165
RF1 · FY2018 · AG · contact PI
ASPirin in Reducing Events in the Elderly$4,941,881
U01 · FY2017 · AG · contact PI
ASPirin in Reducing Events in the Elderly$936,324
U01 · FY2017 · AG · contact PI
ASPirin in Reducing Events in the Elderly$8,983,665
U01 · FY2016 · AG · contact PI
Stroke and Cognitive Impairment in Aging Chronic Kidney Disease Patients$480,201
R01 · FY2015 · AG · contact PI
Stroke and Cognitive Impairment in Aging Chronic Kidney Disease Patients$520,215
R01 · FY2014 · AG · contact PI
Stroke and Cognitive Impairment in Aging Chronic Kidney Disease Patients$61,683
R01 · FY2014 · AG · contact PI
Stroke and Cognitive Impairment in Aging Chronic Kidney Disease Patients$515,433
R01 · FY2013 · AG · contact PI
Stroke and Cognitive Impairment in Aging Chronic Kidney Disease Patients$542,771
R01 · FY2012 · AG · contact PI
Stroke and Cognitive Impairment in Aging Chronic Kidney Disease Patients$556,761
R01 · FY2011 · AG · contact PI
Epidemiology of Dementia in Older Dialysis Patients$148,826
K23 · FY2007 · AG · contact PI
Epidemiology of Dementia in Older Dialysis Patients$150,003
K23 · FY2006 · AG · contact PI
Epidemiology of Dementia in Older Dialysis Patients$148,551
K23 · FY2005 · AG
Epidemiology of Dementia in Older Dialysis Patients$151,366
K23 · FY2004 · AG
Epidemiology of Dementia in Older Dialysis Patients$150,899
K23 · FY2003 · AG